VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
USNAUSANA Health Sciences, Inc.
$18.88$348M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksUSNAPrice Target
USNA logo

USANA Health Sciences, Inc. (USNA) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Hold
Based on 8 analysts

85.4% Below Target

USNA trades 85.4% below Wall Street's consensus target of $35.00.

Current Price$18.88
Average Target$35.00
Low$35.00
Median$35.00
High$35.00

Analyst Target Range

Forward P/E10.9x
(Value)
PEG Ratio—
Implied Growth+196.0%
(High Growth)
Analyst Spread0.0%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$18.88
Consensus$35.00
High$35.00
Low$35.00

Consensus Scenario Assumptions

The base valuation assumes USNA achieves its forward estimates and maintains a stable P/E multiple of 10.9x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 8 published analyst recommendations for USNA

63% hold / mixed conviction
+6
BearishBullish
Weighted analyst sentiment score based on 8 ratings
ConsensusHold
Coverage8 Analysts
Net Score+6
Bull / Bear25% / 13%
Strong Buy00%
Buy225%
Hold563%
Sell113%
Strong Sell00%
Strong Buy
00%
Buy
225%
Hold
563%
Sell
113%
Strong Sell
00%
Recommendation Mix25% Buy · 63% Hold · 13% Sell
Buy (2)Hold (5)Sell (1)

USNA Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, USANA Health Sciences, Inc. (USNA) has a Wall Street consensus price target of $35.00, based on estimates from 8 covering analysts. With the stock currently trading at $18.88, this represents a potential upside of +85.4%. The company has a market capitalization of $348M.

Analyst price targets range from a low of $35.00 to a high of $35.00, representing a 0% spread in expectations. The median target of $35.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.

From a valuation perspective, USNA trades at a trailing P/E of 32.6x and forward P/E of 10.9x. Analysts expect EPS to grow +196.0% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $50.89, with bear and bull scenarios of $32.06 and $67.05 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Consumer Defensive stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+133.8%
Industry Consensus
Avg Forward P/E
12.4x
(Value)
Peers with Coverage
9 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
NUS logo
NUSNu Skin Enterprises, Inc.
$244M$5.02$11.00
+119.1%
Hold5.0x11
NATR logo
NATRNature's Sunshine Products, Inc.
$354M$20.12$37.00
+83.9%
Buy16.7x4
NHTC logo
NHTCNatural Health Trends Corp.
$20M$1.82—————
HLF logo
HLFHerbalife Nutrition Ltd.
$1.2B$11.90$18.50
+55.5%
Buy4.5x26
PLBY logo
PLBYPlayboy, Inc.
$135M$1.45$12.63
+771.0%
Buy—8
ATGE logo
ATGEAdtalem Global Education Inc.
$3.7B$106.64$138.00
+29.4%
Buy13.4x3
MGPI logo
MGPIMGP Ingredients, Inc.
$351M$16.44$29.00
+76.4%
Buy10.3x14
VITL logo
VITLVital Farms, Inc.
$446M$10.41$12.86
+23.5%
Buy—16
AMZN logo
AMZNAmazon.com, Inc.
$2.6T$244.39$307.77
+25.9%
Buy27.8x94
INGR logo
INGRIngredion Incorporated
$6.2B$97.93$117.00
+19.5%
Hold9.1x21

USNA — Frequently Asked Questions

Quick answers to the most common questions about buying USNA stock.

What is the USNA stock price target for 2026?

The consensus Wall Street price target for USNA is $35, representing 85.4% upside from the current price of $18.88. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is USNA a buy, sell, or hold?

USNA has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $35 implies 85.4% upside from current levels.

Is USNA stock overvalued or undervalued?

With a forward P/E of 10.8506x, USNA trades at a relatively low valuation. The consensus target of $35 implies 85.4% appreciation, suggesting meaningful undervaluation.

How high can USNA stock go?

The most bullish Wall Street analyst has a price target of $35 for USNA, while the most conservative target is $35. The consensus of $35 represents the median expectation. Our quantitative valuation model projects a bull case target of $67 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover USNA stock?

USNA is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 5 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the USNA stock forecast?

The 12-month USNA stock forecast based on 8 Wall Street analysts shows a consensus price target of $35, with estimates ranging from $35 (bear case) to $35 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $51, with bear/bull scenarios of $32/$67.

What is USNA's fair value based on fundamentals?

Our quantitative valuation model calculates USNA's fair value at $51 (base case), with a bear case of $32 and bull case of $67. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.

What is USNA's forward P/E ratio?

USNA trades at a forward P/E ratio of 10.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 32.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy USNA stock?

Wall Street analysts are very optimistic on USNA, with a "Hold" consensus rating and $35 price target (85.4% upside). 2 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do USNA price targets vary so much?

USNA analyst price targets range from $35 to $35, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $35 consensus represents the middle ground. Our model's $32-$67 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare